ATE53591T1 - Verfahren zur reinigung von gamma-interferon. - Google Patents

Verfahren zur reinigung von gamma-interferon.

Info

Publication number
ATE53591T1
ATE53591T1 AT85400190T AT85400190T ATE53591T1 AT E53591 T1 ATE53591 T1 AT E53591T1 AT 85400190 T AT85400190 T AT 85400190T AT 85400190 T AT85400190 T AT 85400190T AT E53591 T1 ATE53591 T1 AT E53591T1
Authority
AT
Austria
Prior art keywords
interferon
gamma
solution
gamma interferon
activity
Prior art date
Application number
AT85400190T
Other languages
English (en)
Inventor
Leonard F Estis
Original Assignee
Interferon Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interferon Sciences Inc filed Critical Interferon Sciences Inc
Application granted granted Critical
Publication of ATE53591T1 publication Critical patent/ATE53591T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/249Interferons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/57IFN-gamma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/811Interferon
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/829Blood

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT85400190T 1984-02-07 1985-02-05 Verfahren zur reinigung von gamma-interferon. ATE53591T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/577,908 US4499014A (en) 1984-02-07 1984-02-07 Method for purifying gamma-interferon
EP85400190A EP0152346B1 (de) 1984-02-07 1985-02-05 Verfahren zur Reinigung von gamma-Interferon

Publications (1)

Publication Number Publication Date
ATE53591T1 true ATE53591T1 (de) 1990-06-15

Family

ID=24310633

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85400190T ATE53591T1 (de) 1984-02-07 1985-02-05 Verfahren zur reinigung von gamma-interferon.

Country Status (6)

Country Link
US (1) US4499014A (de)
EP (1) EP0152346B1 (de)
JP (1) JPS6187698A (de)
AT (1) ATE53591T1 (de)
CA (1) CA1237669A (de)
DE (1) DE3578181D1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
FR2560212B1 (fr) * 1984-02-24 1989-12-29 Unicet Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
US4743560A (en) * 1984-03-26 1988-05-10 Becton Dickinson And Company Solid phase assay
NL8501682A (nl) * 1985-06-11 1987-01-02 Tno Nieuw, uit bloed geisoleerd eiwit, werkwijze ter bereiding van dit eiwit, antilichamen tegen het nieuwe eiwit en farmaceutische preparaten, die het eiwit of de antilichamen bevatten.
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
FR2584418B1 (fr) * 1985-07-05 1988-11-10 Unicet Laboratoires Anticorps monoclonaux contre le g-interferon, hybridomes produisant de tels anticorps, procede de preparation de tels anticorps et de tels hybridomes, leur utilisation pour differencier les gifs, et ensemble ou " kit " utilisant de tels anticorps
DK580789D0 (da) * 1989-11-20 1989-11-20 Novo Nordisk As Fremgangsmaade til oprensning af polypeptider
US7045333B1 (en) * 1998-01-16 2006-05-16 Incyte Corporation Human protease molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4184917A (en) * 1974-04-01 1980-01-22 Sandoz Ltd. Process for producing a structurally modified interferon
NL7404590A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het reactiveren van interferon.
FR2351665A1 (fr) * 1976-05-21 1977-12-16 Elf Aquitaine Procede de purification de preparations possedant notamment une activite interferon, preparations purifiees ainsi obtenues et leur application en tant que medicament
DK485977A (da) * 1977-11-01 1979-05-02 Ess Foodeksport Fremgangsmaade til udvinding af et biologisk aktivt materiale fra svineblodfraktioner
IN150740B (de) * 1978-11-24 1982-12-04 Hoffmann La Roche
JPS55154919A (en) * 1979-05-24 1980-12-02 Hayashibara Takeshi Preparation of interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
JPS5651995A (en) * 1979-10-05 1981-05-09 Green Cross Corp:The Preparation of interferon
US4252791A (en) * 1979-10-19 1981-02-24 The Medical College Of Wisconsin, Inc. Interferon stabilization
NL7907791A (nl) * 1979-10-23 1981-04-27 Stichting Rega V Z W Werkwijze voor het zuiveren van interferon.
US4440675A (en) * 1981-08-18 1984-04-03 Meloy Laboratories, Inc. Human immune interferon
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
US4432895A (en) * 1982-11-24 1984-02-21 Hoffmann-La Roche Inc. Monomeric interferons
US4485017A (en) * 1982-12-22 1984-11-27 Cetus Corporation Isolation of human interferon by immunosorbent and high performance liquid chromatography

Also Published As

Publication number Publication date
DE3578181D1 (de) 1990-07-19
EP0152346B1 (de) 1990-06-13
EP0152346A3 (en) 1986-09-10
US4499014A (en) 1985-02-12
EP0152346A2 (de) 1985-08-21
CA1237669A (en) 1988-06-07
JPS6187698A (ja) 1986-05-06
JPH0566400B2 (de) 1993-09-21

Similar Documents

Publication Publication Date Title
DE3585147D1 (de) Verfahren zur reinigung von proteinen.
DE3681058D1 (de) Verfahren zur extraktion und reinigung von proteinen aus dieselben erzeugenden naehrloesungen.
YU45871B (sh) Polipeptid sa humanim imunointerferonskim (ifn-gama) svojstvima
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
YU47735B (sh) Postupak za sintezu biološki aktivnih polipeptida limfotoksina
FI943368A (fi) Mentelmä laktoferriinin ja laktoperoksidaasin eristämiseksi maidosta ja maitotuotteista ja menetelmällä saadut tuotteet
EP0208215A3 (en) Purification of blood clotting factors and other blood proteins on non-carbohydrate sulfated matrices
ATE113960T1 (de) Proteingewinnung.
DE3583439D1 (de) Verfahren zur heizung von zu verbindenden metallelementen.
ATE53591T1 (de) Verfahren zur reinigung von gamma-interferon.
ATE47883T1 (de) Verfahren zur selektiven erhoehung des anteiles von einzelnen hauptkomponenten des teicoplanin a2-komplexes.
DE3576362D1 (de) Verfahren zur reinigung einer physiologisch aktiven substanz, die durch rekombinante dna-technik hergestellt wurde.
MY108512A (en) Method of purifying protein
ES521030A0 (es) Metodo de preparar aminoaminoacidos y analogos.
EP0138092A3 (en) Method of amino acid analysis
EP0188262A3 (de) Verfahren zur Isolierung von Hühnereiweisscystatin, antivirale Agenzien die sie enthalten und seine Verwendung als viraler Protease-Inhibitor
ATE47536T1 (de) Fluid-crack-katalysator und verfahren zur herstellung.
DE3574594D1 (de) Verfahren zur reinigung von riboflavin.
DE58900223D1 (de) Verfahren zur reinigung von 2-hydroxy-naphthalin-6-carbon-saeure.
DE3874667D1 (de) Verfahren zur reinigung von methacrylsaeure.
ATE272072T1 (de) Verfahren zur reinigung von menschlichem interleukin-1 rezeptor antagonist aus rekombinanten e.coli
DE3575163D1 (de) Verfahren zur kultivierung transformierter hefe.
DE3678189D1 (de) Verfahren zur herstellung von aminoalkoholen durch elektrochemische reduktion von nitroalkoholen.
DE3869860D1 (de) Verfahren zur racemisierung von optisch aktiver chrysanthemumsaeure oder deren derivaten.
RO83665A2 (ro) Compozitie catalitica folosita la obtinerea acizilor nesaturati